Cargando…

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study

BACKGROUND: International guidelines recommend at least three months anticoagulation in all patients after acute venous thromboembolism (VTE) and suggest those with unprovoked events be considered for indefinite anticoagulation if the risk of recurrence is high and the risk of bleeding during treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palareti, Gualtiero, Bignamini, Angelo A., Cini, Michela, Li, Young-Jun, Urbanek, Tomasz, Madaric, Juraj, Bouslama, Kamel, Sokurenko, German Y., Andreozzi, Giuseppe M., Matuška, Jiří, Mansilha, Armando, Barinov, Victor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674483/ https://www.ncbi.nlm.nih.gov/pubmed/34841907 http://dx.doi.org/10.1177/10760296211049402

Ejemplares similares

Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Andreozzi, Giuseppe M., et al.
Publicado: (2015)

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
por: Palareti, Gualtiero
Publicado: (2012)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
por: Pompilio, Giuseppe, et al.
Publicado: (2020)

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays
por: Cini, Michela, et al.
Publicado: (2019)

Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017)

Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study
por: Tasaka, Nobutaka, et al.
Publicado: (2023)

Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis
por: Bignamini, Angelo A., et al.
Publicado: (2020)

D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants
por: Legnani, Cristina, et al.
Publicado: (2019)

Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register
por: Palareti, Gualtiero, et al.
Publicado: (2021)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Management of Haemarthrosis in Patients On Oral Anticoagulants
por: Dalrymple, James, et al.
Publicado: (2022)

Venous Thromboembolism in Japanese Patients With Pancreatic Cancer
por: Suzuki, Takahito, et al.
Publicado: (2021)

Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
por: Suzuki, Takahito, et al.
Publicado: (2023)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer
por: Qin, Ya, et al.
Publicado: (2023)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Thromboembolic risk in pregnant women with SARS-CoV-2 infection – A systematic review
por: Leal, Diana, et al.
Publicado: (2022)

Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
por: Allende-Pérez, Silvia Rosa, et al.
Publicado: (2022)

Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness
por: Wang, Zibin, et al.
Publicado: (2023)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
por: Kornfehl, Andrea, et al.
Publicado: (2023)

Hospital Variation and Associated Organizational Factors of Pregnancy-Related Venous Thromboembolism in China
por: Zhou, Qiongjie, et al.
Publicado: (2022)

Risk Factor Analysis of Postoperative Venous Thromboembolism in Patients After Thoracoscopic Lobectomy
por: Qiao, Junkai, et al.
Publicado: (2023)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty
por: Bala, Abiram, et al.
Publicado: (2021)

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population
por: Jin, Xiuri, et al.
Publicado: (2021)

Multidisciplinary Bundle Approach in Venous Thromboembolism Prophylaxis in Patients with Non-Traumatic Subarachnoid Hemorrhage
por: Phan, Brian, et al.
Publicado: (2022)

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States
por: Peacock, W. Frank, et al.
Publicado: (2022)

Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
por: Sun, Shuai, et al.
Publicado: (2022)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Reversal of Oral Anticoagulants: A Survey of Contemporary Practice Trends (ReACT)
por: Deng, Huiwen, et al.
Publicado: (2023)

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
por: Wang, Yuhan, et al.
Publicado: (2022)

Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden
por: Glise Sandblad, Katarina, et al.
Publicado: (2023)

Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism
por: Duan, Rundan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmf8qmvmp1t5fnci0pkvps6iuq